Who Just RaisedSeattle, WA · Health Care · Form D filed Aug 26, 2026
Aptevo Therapeutics Inc. raised $3.5M
Aptevo Therapeutics Inc. is a pharmaceutical company based in Seattle, Washington. In a Form D filed with the SEC on August 26, 2026, it reported raising $3,472,683 from 3 investors as part of an offering of up to $3,472,683. The first sale in the offering took place on August 12, 2026.
- 2nd Form D since 2025. Earlier new notices: Apr 18, 2025. All filings on EDGAR
- Rule 506(c) offering. The company may advertise this round publicly; buyers must be verified accredited investors.
$5.6M raised since 2020
2 Form D offerings, as reported to the SEC, the first in Apr 18, 2025. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 26, 2026 | $3.5M | $3.5M | 3 |
| Apr 18, 2025 | $2.1M | $2.1M | 11 |
Placement agent: Roth Capital Partners, LLC
Lead score
20 out of 100
early raise budget to spend website found
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- aptevotherapeutics.com
- Amount raised
- $3,472,683
- Offering size
- $3,472,683
- Investors so far
- 3
- First sale
- August 12, 2026
- Securities offered
- Equity, Options or warrants
- Exemption claimed
- Rule 506(c)
- Industry
- Pharmaceuticals
- Headquarters
- Seattle, Washington
- Incorporated
- Delaware
- Entity type
- Corporation
- Revenue range
- No Revenues
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $3,472,683 | $3,472,683 | 3 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 24, 2026 · Health Care funding in Washington · August 2026 funding report
Similar raises
Life Stylistic, Inc.
Seattle, WA · filed Oct 15
Cultural commerce solutions.
First Form DStill raising
LevelTen Energy, Inc.
Seattle, WA · filed Oct 810th Form D since 2017
CytoTerra Inc.
Seattle, WA · filed Oct 72nd Form D since 2026Still raising
Q-Immune, Inc.
Seattle, WA · filed Sep 28
CAR-T can cure. Q-Immune makes it safe, with a lab that teaches AI how engineered cells behave.
First Form DStill raising
Seattle Neurosound Solutions, Inc.
Seattle, WA · filed Sep 22First Form DStill raising
Hexamer Therapeutics, Inc
Pullman, WA · filed Sep 153rd Form D since 2019Still raising
DexCare, Inc.
Seattle, WA · filed Sep 143rd Form D since 2021Still raising
MalarVx, Inc.
Seattle, WA · filed Aug 254th Form D since 2012Still raising